[Anticoagulant therapy in cardiovascular diseases.]

[Anticoagulant therapy in cardiovascular diseases.] Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

[Anticoagulant therapy in cardiovascular diseases.] Abstract Text:

V DEBENEDETTI,M RAVERA,

[Anticoagulant therapy in cardiovascular diseases.] Publishing Authors By Initials

V DEBENEDETTI,M RAVERA,

For similar cardiovascular diseases research abstracts see: cardiovascular diseases research

PUBMED ID PMID:

MEDLINE DATE:

[Anticoagulant therapy in cardiovascular diseases.] Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Atti della Società italiana di cardiologia

VOLUME: 1

Page Numbers: 389-91

Journal Abbreviation:

ISSN: 0081-069X

DAY: 24

MONTH: 01

YEAR: 1956

[Anticoagulant therapy in cardiovascular diseases.] Information

Number of References:

LANGUAGE: ita

NlmUniqueID: 7506884

[Anticoagulant therapy in cardiovascular diseases.] Keywords Mesh Terms:

KEYWORDS: Cardiovascular Diseases

MESH TERMS: therapy

Chemical & Substance for Abstract: [Anticoagulant therapy in cardiovascular diseases.] Information

Substance Name: coumarin

Registry Number: 91-64-5

Grant and Affiliation Information for [Anticoagulant therapy in cardiovascular diseases.]

AFFILIATION:

Country: Not Available

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Atti Soc Ital Cardiol

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Anticoagulant therapy in cardiovascular diseases Related Publications

• A 4- to 6-year retrospective clinical study of cracked teeth restored with bonded indirect resin composite onlays.
• Anorexia in cancer patients: Prevalence and impact on the nutritional status.
• Risk factors for posterior cystoid retinal degeneration in central serous chorioretinopathy.
• [A new coumarin derivative anticoagulant: sintrom (G 23350); clinical & experimental researches.]
• [Anticoagulant therapy in cardiovascular diseases.]
• [Arterial hypertension caused by primary malignant adrenocortical tumor.]
• [Behavior of eosinophils and of 17-ketosteroid and 11-oxycortico-steroids und influence of small and large doses of penicillin.]
• [Behavior of prothrombin factors during treatment with anticoagulants of the coumarin & indandione series.]
• [Elimination of uropepsin in normal subjects of both sexes.]
• [Elimination of uropepsin in patients of various diseases.]
• [Not Available.]
• [Not Available.]
• [Not Available.]
• [Not Available.]
• [Not Available.]
• [Our experience with anticoagulant therapy.]